Evidence map›Paper›PMID 32269047›Full record

ArticleBMJ case reports2020

Case of using mycophenolate in combination with steroids for concurrent macrophage activation syndrome and lupus flare.

Kavina Shah, Andrew Porter, Gagandeep Takhar, Venkat Reddy

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kavina ShahRheumatology Department, West Middlesex University Hospital NHS Trust, London, UK kavina.shah@ucl.ac.uk.
Andrew PorterRheumatology Department, West Middlesex University Hospital NHS Trust, London, UK.
Gagandeep TakharRheumatology Department, West Middlesex University Hospital NHS Trust, London, UK.
Venkat ReddyCentre for Rheumatology, University College London, London, UK.
West Middlesex University Hospital · GBUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This report highlights the importance of tailored treatment strategies in severe systemic lupus erythematosus (SLE) flares driving the life-threatening condition, macrophage activation syndrome (MAS). We report the case of a 42-year-old woman with active systemic lupus erythematosus (SLE) who was diagnosed with MAS within 3 days of onset of lethargy, rash, joint pain and significant cytopenias. This early diagnosis meant that her condition was managed with less intensive immunosuppression with only modest doses of steroids and mycophenolate mofetil.

Indexed as

AdultDiagnosis, DifferentialDrug Therapy, CombinationEnzyme InhibitorsFemaleGlucocorticoidsHumansLupus Erythematosus, SystemicMacrophage Activation SyndromeMycophenolic AcidPrednisoloneEnzyme InhibitorsGlucocorticoidsMycophenolic AcidPrednisoloneconnective tissue diseasehaematology (incl blood transfusion)rheumatologysystemic lupus erythematosus

Identifiers

PMID32269047
PMCPMC7167458
OpenAlexW3015591409

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.